Community pharmacists must be well-equipped to advance pharmacogenomics services. Nevertheless, limited data is available regarding pharmacists' knowledge and attitudes toward pharmacogenomics testing. The present study aimed to evaluate community pharmacists' knowledge and attitudes toward pharmacogenomics testing in the UAE. In this cross-sectional study, a validated, online, self-administered survey, was randomly distributed to community pharmacists across the United Arab Emirates (UAE). The participants demonstrated poor knowledge about pharmacogenomic testing (median score < 8). Having 10–29 (Adjusted odds ration [AOR]: 0.038; 95% CI: 0.01–0.146, p = 0.001) and 30–49 (AOR: 0.097; 95% CI: 0.04–0.237, p = 0.001) patients per day was associated with poorer knowledge. Also, receiving 10–29 (AOR: 0.046; 95% CI: 0.005–0.401, p = 0.005), 30–49 (AOR: 0.025; 95% CI: 0.003–0.211, p = 0.001), and > 50 (AOR: 0.049; 95% CI: 0.005–0.458, p = 0.008) prescriptions decreased the odds of having good knowledge. Around half (43.9%) of the participants did not show a positive attitude toward pharmacogenomic testing (median score < 11). Having 30–49 patients per day (AOR: 5.351; 95% CI: 2.414–11.860, p = 0.001) increased the odds of good knowledge while receiving 10–29 (AOR: 0.133; 95% CI: 0.056–0.315, p = 0.001) and 30–49 (AOR: 0.111; 95% CI: 0.049–0.252, p = 0.001) prescriptions a day were associated with decreased odds of positive attitude toward the pharmacogenomics testing. The findings indicate a lack of knowledge and less-than-ideal attitudes among community pharmacists regarding pharmacogenomics testing. Enhanced efforts focused on educational initiatives and training activities related to pharmacogenomics testing is needed. Additionally, reducing workload can facilitate better knowledge acquisition and help mitigate unfavorable attitudes.

中文翻译：

---

社区药师对药物基因组学检测的知识和态度的调查：对改进药物基因组学检测实践的启示

社区药剂师必须具备良好的能力来推进药物基因组学服务。然而，关于药剂师对药物基因组学测试的知识和态度的数据有限。本研究旨在评估阿联酋社区药剂师对药物基因组学测试的知识和态度。在这项横断面研究中，一项经过验证的在线自我管理调查被随机分发给阿拉伯联合酋长国 (UAE) 的社区药剂师。参与者对药物基因组学测试的了解很少（中位数<8）。每天有 10-29 名（调整比值比 [AOR]：0.038；95% CI：0.01-0.146，p = 0.001）和 30-49 名（AOR：0.097；95% CI：0.04-0.237，p = 0.001）患者与知识匮乏有关。此外，接收 10–29（AOR：0.046；95% CI：0.005–0.401，p = 0.005）、30–49（AOR：0.025；95% CI：0.003–0.211，p = 0.001）和 > 50（AOR ：0.049；95% CI：0.005–0.458，p = 0.008）处方降低了拥有良好知识的几率。大约一半（43.9%）的参与者对药物基因组学测试没有表现出积极的态度（中位数<11）。每天接待 30-49 名患者（AOR：5.351；95% CI：2.414-11.860，p = 0.001），在接待 10-29 名患者（AOR：0.133；95% CI：0.056-0.315，p = 0.001）时，获得良好知识的几率增加每天 30-49 个（AOR：0.111；95% CI：0.049-0.252，p = 0.001）处方与对药物基因组学测试持积极态度的几率降低相关。研究结果表明，社区药剂师对药物基因组学测试缺乏知识，态度也不太理想。需要加强重点关注与药物基因组学测试相关的教育举措和培训活动。此外，减少工作量可以促进更好的知识获取并有助于减轻不利态度。